Researchers Map Tau Modifications Across Tauopathies
Boston Children's Hospital researchers led by Judith A. Steen and Hanno Steen analyzed brain tissue from 203 patients across multiple tauopathies using FLEXITau mass spectrometry to absolutely quantify 145 post‑translational modifications and 195 cleavage sites. Machine‑learning models ranked disease‑discriminant molecular features, producing a validated molecular atlas that aims to guide precision diagnostics, imaging, and therapeutic target selection across tau-mediated neurodegeneration.
Scoring Rationale
Strong quantitative atlas and validation provide actionable targets, limited mainly by disease heterogeneity and translational steps.
Practice interview problems based on real data
1,500+ SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
